Moura FA, Kamanu FK, Wiviott SD, et al. Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancers. Diabetes, obesity & metabolism. 2024. doi:10.1111/dom.16123
Publications
Musa SS, Zhao S, Mkandawire W, Colubri A, He D. An epidemiological modeling investigation of the long-term changing dynamics of the plague epidemics in Hong Kong. Mathematical biosciences and engineering : MBE. 2024;21(10):7435-7453. doi:10.3934/mbe.2024327
Hart RK, Fokkema IFAC, DiStefano M, et al. HGVS Nomenclature 2024: improvements to community engagement, usability, and computability. Genome medicine. 2024;16(1):149. doi:10.1186/s13073-024-01421-5
Ruiz-Torres DA, Wise JF, Zhao BY, et al. Dendritic cell effector mechanisms and tumor immune microenvironment infiltration define TLR8 modulation and PD-1 blockade. Frontiers in immunology. 2024;15:1440530. doi:10.3389/fimmu.2024.1440530
Akbarialiabad H, Seyyedi MS, Paydar S, Habibzadeh A, Haghighi A, Kvedar JC. Bridging silicon and carbon worlds with digital twins and on-chip systems in drug discovery. NPJ systems biology and applications. 2024;10(1):150. doi:10.1038/s41540-024-00476-9
Owsley DW, Bruwelheide KS, Harney E, et al. Historical and Archaeogenomic Identification of High-Status Englishmen at Jamestown, Virginia. Antiquity. 2024;98(400):1040-1054. doi:10.15184/aqy.2024.75
Gu B, Desai RJ, Lin KJ, Yang J. Probabilistic medical predictions of large language models. NPJ digital medicine. 2024;7(1):367. doi:10.1038/s41746-024-01366-4
Veselka B, Reich D, Capuzzo G, et al. Assembling Ancestors: the manipulation of Neolithic and Gallo-Roman skeletal remains from Pommerœul, Belgium. Antiquity. 2024;98(402):1576-1591. doi:10.15184/aqy.2024.158
Watanabe A, Neves PDM de M, Nunes K, et al. Steroid-Resistant Nephrotic Syndrome Is Associated With a Unique Genetic Profile in a Highly Admixed Pediatric Population. Kidney international reports. 2024;9(12):3501-3516. doi:10.1016/j.ekir.2024.09.005
Torun A, Zdanowicz A, Miazek-Zapala N, et al. Potassium/sodium cation carriers robustly up-regulate CD20 antigen by targeting MYC, and synergize with anti-CD20 immunotherapies to eliminate malignant B cells. Haematologica. 2024. doi:10.3324/haematol.2024.285826